Abstract
This topic was to examine the impact of galactose or fructose upon the assimilation of secondary carbon sources by Candida albicans. C. albicans ICL1 gene is repressed upon addition of 2% galactose or fructose to lactate- and oleic acid-grown cells. Further studies on CaFOX2, CaFBP1 and CaMLS1 transcripts in response to galactose or fructose on assimilation of lactate and oleic acid resulted in repression of these genes. The CaICL1 gene, which encode the glyoxylate cycles enzymes isocitrate lyase are required for growth on non-fermentable carbon sources. However, the enzyme CaIcl1 was not destabilized by galactose, but was degraded in response to fructose. In contrast, S. cerevisiae Icl1 has retained the molecular apparatus of protein degradation in response to either galactose or fructose. Screening of ubiquitination site by http://www.ubpred.org/ showed that C. albicans lacks ubiquitination site in gluconeogenic and glyoxylate cycles enzymes as compare to S. cerevisiae. Addition of a putative S. cerevisiae ubiquitination site carboxy terminus of CaIcl1 led to galactose- accelerated degradation of this protein in C. albicans cell via a ubiquitin-dependent process. In the other hand, CaIcl prior to addition of ubiquitination site was degraded upon exposure to fructose; addition of S. cerevisiae ubiquitination site to CaIcl1 further increased the speed of protein degradation.
Keywords
- Candida albicans
- galactose
- fructose
- glyoxylate cycles
- isocitrate lyase
- gluconeogenic
- metabolic adaptation
- protein degradation
- ubiquitination
1. Introduction
In order to proliferate in a wide range of environmental niches, pathogens must not only depend on certain virulence factors, it is also important to have a flexible metabolism; therefore, they can assimilate a variety of carbon sources that are scarce or the only available carbon source at a specific environmental niche. The primary and preferred sources of metabolic carbon for most organisms are carbohydrates; it is used for generating energy and producing biomolecules. Before entering the glycolytic pathway, most sugars are converted to fructose-6-phosphate or glucose-6-phosphate. ATP and NADH are produced from the conversion of hexose phosphates into the key metabolite pyruvate in glycolysis pathway. From there, two major strategies of energy production (fermentation and respiration) are carried out by cells. Although NAD+ is regenerated by both processes, respiration is more efficient than fermentation as it produces additional ATP through the oxidative phosphorylation and tricarboxylic acid (TCA) cycle. Glycolysis is the central, common pathway for both processes and it is critical for carbon assimilation; the pathway has been shown to be up-regulated during infections and important to the virulence in pathogenic bacteria, parasites, and fungi [10, 11, 12]. Glycolysis, gluconeogenesis, and the glyoxylate cycle are part of
Central metabolic pathway such as glycolysis is strictly regulated, transcript of glycolytic enzymes is regulated in response to environmental conditions such as carbon source and availability, oxygen levels, and to cellular demands such as energy needs and metabolite concentrations. However, the regulators of glycolytic gene expression in most species have not been identified; for eukaryotes understanding of transcriptional control of glycolysis is mainly based on the non-pathogenic yeast
Gluconeogenesis is required for yeast cells to generate sugar phosphates for the synthesis of essential cellular components, during the growth on non-fermentable carbon sources. Under physiological conditions with two exceptions, most of the glycolytic reactions are reversible. In many yeasts including
The glyoxylate cycle is a “modified tricarboxylic acid (TCA) cycle,” instead of the two decarboxylation steps of the TCA cycle the key enzymes of the glyoxylate cycle (isocitrate lyase,
Fatty acids are broken down in the mitochondria by catabolic process (beta oxidation) to generate two-carbon units (Acetyl-CoA), which can be oxidized to CO2 and H2O via the TCA cycle or used to generate hexose via the glyoxylate and gluconeogenesis, and NADH and FADH2, which are co-enzymes used in electron transport chain. In yeast
Glyoxylate cycle is present in fungi but not in mammals, and β-oxidation of fatty acids develop in different directions between mammals and fungi. Therefore, in order to have a better understand on the importance of these pathways, physiological and virulence of mutant strains lacking of these genes encoding key enzymes the β-oxidation multifunctional protein (
In the present of glucose
Not much is known about how
Similar observation is observed between
Similar to that in
Lorenz and Fink [27] have proved the importance of key enzyme,
Thus, it is important to have a better understanding and studying the mechanism involved, and the fitness attribute of the key enzymes in central metabolism of
2. Effect of galactose or fructose on C. albicans FOX2, FBP1, MLS1 and ICL1 mRNAs
There are reports that state repression on transcriptome by glucose in
Global transcriptional responses of
3. Role of ubiquitination in sugar phosphate-accelerated protein degradation in C. albicans
Research done by Sandai et al. [35] suggested that
Ubiquitination play an important role in the glucose-accelerated degradation of gluconeogenic enzymes in
Based on this bioinformatics comparison, the ScIcl sequence containing strong consensus ubiquitination sites at amino acid 158 and 551, but there is a lack of high confidence ubiquitin target in CaIcl1, CaMls1, ScMls1, CaFbp1 and ScFbp1 (Figure 1). Interestingly, CaFox2 contain one strong consensus ubiquitination site at amino acid 588, but there is none high confidence ubiquitination target in ScFox2. This prediction was based on high level of confidence which is described in UbPred system containing score range 0.84 ≤ s ≤ 1.00, 0.197 for sensitivity and 0.989 for specificity. However, focus of this study is on Icl1 because it is more important for
The bioinformatics screening of ubiquitination site includes the hydrophobic nature of the ubiquitination target site for high confidence prediction (TEDQFKENGVKK), which is contrast to the low and medium confidence sites which contain acidic and basic residues in the putative ubiquitination site (NGVKK; FNWPKAMSVD) [45, 46]. Therefore, the presence of consensus ubiquitination sites in these proteins correlated with glucose-accelerated degradation [35].
4. Overview of carbon sources attribute to the pathogenicity to C. albicans
The effect of galactose or fructose on the expression levels of the CaIcl protein in
Therefore, as a starting point whether Icl1 decline in
Next was to determine the effect of galactose or fructose addition to
Testing was carried out to see whether
Testing was also carried out to determine whether
5. Conclusion and future perspective
The assimilation of carbon sources is fundamentally important for the growth of
First, gluconeogenic, glyoxylate cycle and β-oxidation mRNAs are sensitive to galactose or fructose in both
Second main observation was that the Icl1 proteins are stable in
Interestingly there is a finding that fructose increases phosphorylation/activation of hypothalamic AMP kinase causing phosphorylation/inactivation of Acetyl-CoA carboxylase, whereas glucose has the inverse effects [59]. This finding is interesting because acetyl-coenzyme A (Acetyl-CoA) is an essential cofactor in central metabolism, this molecule is the entry point to the tricarboxylic acid (TCA) cycle that generates energy, biomass, and intermediates for macromolecules [59]. This means that addition of fructose might repressed Acetyl-CoA in
The third observation whether
The analysis of ubiquitination in
It is interesting to further study the mechanism involved in protein degradation in response to fructose. Why is only fructose and not glucose or galactose that triggers protein degradation of CaIcl1? And which pathways could CaIcl1 take for proteolysis? Is it vacuolar proteolysis or ubiquitin mediated proteolysis, such as ubiquitin conjugating enzyme Ubc8p [43] and E3 ubiquitin ligase, Gid complex [49, 60]? It is also interesting to explore other central metabolism enzymes that carry the same characteristic of CaIcl1 and also to determine the effect of exposure to other carbon sources such as malate and succinate.
Acknowledgments
The first author would like to sincerely thank Universiti Sains Malaysia for providing financial support for this project from the Research University Individual (RUI) grant no: 1001/CIPPT/812196.
References
- 1.
Kurtzman C, Fell JW. The Yeasts—A Taxonomic Study. Elsevier Science; 1998:1076. ISBN 9780080542690 - 2.
Ene IV, Bennett RJ. The cryptic sexual strategies of human fungal pathogens. Nature Reviews. Microbiology. 2014; 12 (4):239-251. DOI: 10.1038/nrmicro3236 - 3.
Hull CM, Johnson AD. Identification of a mating type-like locus in the asexual pathogenic yeast Candida albicans . Science. 1999;285 (5431):1271-1275 - 4.
Calderone RA. Candida and Candidiasis. Washington DC: ASM Press; 2002 - 5.
Sudbery P, Gow N, Berman J. The distinct morphogenic states of Candida albicans . Trends in Microbiology. 2004;12 (7):317-324. DOI: 10.1016/j.tim.2004.05.008 - 6.
Slutsky B, Staebell M, Anderson J, Risen L, Pfaller M, Soll DR. "White-opaque transition": A second high-frequency switching system in Candida albicans . Journal of Bacteriology. 1987;169 (1):189-197 - 7.
Butler G, Rasmussen MD, Lin MF, Santos MA, Sakthikumar S, Munro CA, et al. Evolution of pathogenicity and sexual reproduction in eight Candida genomes. Nature. 2009; 459 (7247):657-662. DOI: 10.1038/nature08064 - 8.
Bennett RJ, Johnson AD. Completion of a parasexual cycle in Candida albicans by induced chromosome loss in tetraploid strains. The EMBO Journal. 2003;22 (10):2505-2515. DOI: 10.1093/emboj/cdg235 - 9.
Forche A, Alby K, Schaefer D, Johnson AD, Berman J, Bennett RJ. The parasexual cycle in Candida albicans provides an alternative pathway to meiosis for the formation of recombinant strains. PLoS Biology. 2008;6 (5):e110. DOI: 10.1371/journal.pbio.0060110 - 10.
Barelle CJ, Priest CL, Maccallum DM, Gow NA, Odds FC, Brown AJ. Niche-specific regulation of central metabolic pathways in a fungal pathogen. Cellular Microbiology. 2006; 8 (6):961-971. DOI: 10.1111/j.1462-5822.2005.00676.x - 11.
Costa M, Borges CL, Bailao AM, Meirelles GV, Mendonca YA, Dantas SF, et al. Transcriptome profiling of Paracoccidioides brasiliensis yeast-phase cells recovered from infected mice brings new insights into fungal response upon host interaction. Microbiology. 2007;153 (Pt 12):4194-4207. DOI: 10.1099/mic.0.2007/009332-0 - 12.
Rodaki A, Young T, Brown AJ. Effects of depleting the essential central metabolic enzyme fructose-1,6-bisphosphate aldolase on the growth and viability of Candida albicans : Implications for antifungal drug target discovery. Eukaryotic Cell. 2006;5 (8):1371-1377. DOI: 10.1128/EC.00115-06 - 13.
Chambers A, Packham EA, Graham IR. Control of glycolytic gene expression in the budding yeast ( Saccharomyces cerevisiae ). Current Genetics. 1995;29 (1):1-9 - 14.
Clifton D, Weinstock SB, Fraenkel DG. Glycolysis mutants in Saccharomyces cerevisiae . Genetics. 1978;88 (1):1-11 - 15.
Uemura H, Fraenkel DG. gcr2, a new mutation affecting glycolytic gene expression in Saccharomyces cerevisiae . Molecular and Cellular Biology. 1990;10 (12):6389-6396 - 16.
Baker HV. GCR1 of Saccharomyces cerevisiae encodes a DNA binding protein whose binding is abolished by mutations in the CTTCC sequence motif. Proceedings of the National Academy of Sciences of the United States of America. 1991;88 (21):9443-9447 - 17.
Clifton D, Fraenkel DG. The gcr (glycolysis regulation) mutation of Saccharomyces cerevisiae . The Journal of Biological Chemistry. 1981;256 (24):13074-13078 - 18.
Nishi K, Park CS, Pepper AE, Eichinger G, Innis MA, Holland MJ. The GCR1 requirement for yeast glycolytic gene expression is suppressed by dominant mutations in the SGC1 gene, which encodes a novel basic-helix-loop-helix protein. Molecular and Cellular Biology. 1995; 15 (5):2646-2653 - 19.
Wisplinghoff H, Ebbers J, Geurtz L, Stefanik D, Major Y, Edmond MB, et al. Nosocomial bloodstream infections due to Candida spp. in the USA: Species distribution, clinical features and antifungal susceptibilities. International Journal of Antimicrobial Agents. 2014;43 (1):78-81. DOI: 10.1016/j.ijantimicag.2013.09.005 - 20.
Askew C, Sellam A, Epp E, Hogues H, Mullick A, Nantel A, et al. Transcriptional regulation of carbohydrate metabolism in the human pathogen Candida albicans . PLoS Pathogens. 2009;5 (10):e1000612. DOI: 10.1371/journal.ppat.1000612 - 21.
Bojunga N, Kotter P, Entian KD. The succinate/fumarate transporter Acr1p of Saccharomyces cerevisiae is part of the gluconeogenic pathway and its expression is regulated by Cat8p. Molecular & General Genetics. 1998;260 (5):453-461 - 22.
Eschrich D, Kotter P, Entian KD. Gluconeogenesis in Candida albicans . FEMS Yeast Research. 2002;2 (3):315-325 - 23.
Kornberg HL, Madsen NB. The metabolism of C2 compounds in microorganisms. 3. Synthesis of malate from acetate via the glyoxylate cycle. The Biochemical Journal. 1958; 68 (3):549-557 - 24.
Piekarska K, Mol E, van den Berg M, Hardy G, van den Burg J, van Roermund C, et al. Peroxisomal fatty acid beta-oxidation is not essential for virulence of Candida albicans . Eukaryotic Cell. 2006;5 (11):1847-1856. DOI: 10.1128/EC.00093-06 - 25.
Ramirez MA, Lorenz MC. Mutations in alternative carbon utilization pathways in Candida albicans attenuate virulence and confer pleiotropic phenotypes. Eukaryotic Cell. 2007;6 (2):280-290. DOI: 10.1128/EC.00372-06 - 26.
Ramirez MA, Lorenz MC. The transcription factor homolog CTF1 regulates {beta}-oxidation in Candida albicans . Eukaryotic Cell. 2009;8 (10):1604-1614. DOI: 10.1128/EC.00206-09 - 27.
Lorenz MC, Fink GR. The glyoxylate cycle is required for fungal virulence. Nature. 2001; 412 (6842):83-86. DOI: 10.1038/35083594 - 28.
Hudson DA, Sciascia QL, Sanders RJ, Norris GE, Edwards PJ, Sullivan PA, et al. Identification of the dialysable serum inducer of germ-tube formation in Candida albicans . Microbiology. 2004;150 (Pt 9):3041-3049. DOI: 10.1099/mic.0.27121-0 - 29.
Bendel CM, Hess DJ, Garni RM, Henry-Stanley M, Wells CL. Comparative virulence of Candida albicans yeast and filamentous forms in orally and intravenously inoculated mice. Critical Care Medicine. 2003;31 (2):501-507. DOI: 10.1097/01.CCM.0000049954.48239.A1 - 30.
Fan J, Chaturvedi V, Shen SH. Identification and phylogenetic analysis of a glucose transporter gene family from the human pathogenic yeast Candida albicans . Journal of Molecular Evolution. 2002;55 (3):336-346. DOI: 10.1007/s00239-002-2330-4 - 31.
Dumitru R, Hornby JM, Nickerson KW. Defined anaerobic growth medium for studying Candida albicans basic biology and resistance to eight antifungal drugs. Antimicrobial Agents and Chemotherapy. 2004;48 (7):2350-2354. DOI: 10.1128/AAC.48.7.2350-2354.2004 - 32.
Johnston M, Kim JH. Glucose as a hormone: Receptor-mediated glucose sensing in the yeast Saccharomyces cerevisiae . Biochemical Society Transactions. 2005;33 (Pt 1):247-252. DOI: 10.1042/BST0330247 - 33.
Ozcan S, Johnston M. Two different repressors collaborate to restrict expression of the yeast glucose transporter genes HXT2 and HXT4 to low levels of glucose. Molecular and Cellular Biology. 1996; 16 (10):5536-5545 - 34.
Brown V, Sexton JA, Johnston M. A glucose sensor in Candida albicans . Eukaryotic Cell. 2006;5 (10):1726-1737. DOI: 10.1128/EC.00186-06 - 35.
Sandai D, Yin Z, Selway L, Stead D, Walker J, Leach MD, et al. The evolutionary rewiring of ubiquitination targets has reprogrammed the regulation of carbon assimilation in the pathogenic yeast Candida albicans . MBio Journal. 2012;3 (6). DOI: 10.1128/mBio.00495-12 - 36.
Leach MD, Stead DA, Argo E, MacCallum DM, Brown AJ. Molecular and proteomic analyses highlight the importance of ubiquitination for the stress resistance, metabolic adaptation, morphogenetic regulation and virulence of Candida albicans . Molecular Microbiology. 2011;79 (6):1574-1593. DOI: 10.1111/j.1365-2958.2011.07542.x - 37.
Sepulveda P, Lopez-Ribot JL, Gozalbo D, Cervera A, Martinez JP, Chaffin WL. Ubiquitin-like epitopes associated with Candida albicans cell surface receptors. Infection and Immunity. 1996;64 (10):4406-4408 - 38.
Roig P, Gozalbo D. Depletion of polyubiquitin encoded by the UBI4 gene confers pleiotropic phenotype to Candida albicans cells. Fungal Genetics and Biology. 2003;39 (1):70-81 - 39.
Leng P, Sudbery PE, Brown AJ. Rad6p represses yeast-hypha morphogenesis in the human fungal pathogen Candida albicans . Molecular Microbiology. 2000;35 (5):1264-1275 - 40.
Cheah HL, Lim V, Sandai D. Inhibitors of the glyoxylate cycle enzyme ICL1 in Candida albicans for potential use as antifungal agents. PLoS One. 2014;9 (4):e95951. DOI: 10.1371/journal.pone.0095951 - 41.
Gancedo JM. Yeast carbon catabolite repression. Microbiology and Molecular Biology Reviews. 1998; 62 (2):334-361 - 42.
Yin Z, Wilson S, Hauser NC, Tournu H, Hoheisel JD, Brown AJ. Glucose triggers different global responses in yeast, depending on the strength of the signal, and transiently stabilizes ribosomal protein mRNAs. Molecular Microbiology. 2003; 48 (3):713-724 - 43.
Ting SY, Ishola OA, Ahmed MA, Tabana YM, Dahham MT, Agha MT, et al. Metabolic adaptation via regulation enzyme degradation in the pathogenic yeast Candida albicans . Journal de Mycologie Medicale. 2017;27 :98-108. DOI: 10.1061/j.mycmed.2016.12.002 - 44.
Schule T, Rose M, Entian KD, Thumm M, Wolf DH. Ubc8p functions in catabolite degradation of fructose-1, 6-bisphosphatase in yeast. The EMBO Journal. 2000; 19 (10):2161-2167. Doi: 10.1093/emboj/19.10.2161 - 45.
Johnson ES, Bartel B, Seufert W, Varshavsky A. Ubiquitin as a degradation signal. The EMBO Journal. 1992; 11 (2):497-505 - 46.
Hitchcock AL, Auld K, Gygi SP, Silver PA. A subset of membrane-associated proteins is ubiquitinated in response to mutations in the endoplasmic reticulum degradation machinery. Proceedings of the National Academy of Sciences of the United States of America. 2003; 100 (22):12735-12740. DOI: 10.1073/pnas.2135500100 - 47.
Rost B. Review: Protein secondary structure prediction continues to rise. Journal of Structural Biology. 2001; 134 (2-3):204-218. DOI: 10.1006/jsbi.2001.4336 - 48.
Hammerle M, Bauer J, Rose M, Szallies A, Thumm M, Dusterhus S, et al. Proteins of newly isolated mutants and the amino-terminal proline are essential for ubiquitin-proteasome-catalyzed catabolite degradation of fructose-1,6-bisphosphatase of Saccharomyces cerevisiae . The Journal of Biological Chemistry. 1998;273 (39):25000-25005 - 49.
Regelmann J, Schule T, Josupeit FS, Horak J, Rose M, Entian KD, et al. Catabolite degradation of fructose-1,6-bisphosphatase in the yeast Saccharomyces cerevisiae : A genome-wide screen identifies eight novel GID genes and indicates the existence of two degradation pathways. Molecular Biology of the Cell. 2003;14 (4):1652-1663. DOI: 10.1091/mbc.E02-08-0456 - 50.
Piskur J, Rozpedowska E, Polakova S, Merico A, Compagno C. How did Saccharomyces evolve to become a good brewer? Trends in Genetics. 2006;22 (4):183-186. DOI: 10.1016/j.tig.2006.02.002 - 51.
Niimi M, Kamiyama A, Tokunaga M. Respiration of medically important Candida species andSaccharomyces cerevisiae in relation to glucose effect. Journal of Medical and Veterinary Mycology. 1988;26 (3):195-198 - 52.
Bertram G, Swoboda RK, Gooday GW, Gow NA, Brown AJ. Structure and regulation of the Candida albicans ADH1 gene encoding an immunogenic alcohol dehydrogenase. Yeast. 1996;12 (2):115-127. DOI: 10.1002/(SICI)1097-0061(199602)12:2<115::AID-YEA889>3.0.CO;2-E - 53.
Odds FC. Candida and Candidosis. Bailliere T, 2nd Edition. London. 1988 - 54.
Vargas SL, Patrick CC, Ayers GD, Hughes WT. Modulating effect of dietary carbohydrate supplementation on Candida albicans colonization and invasion in a neutropenic mouse model. Infection and Immunity. 1993;61 (2):619-626 - 55.
Holden HM, Rayment I, Thoden JB. Structure and function of enzymes of the leloir pathway for galactose metabolism. The Journal of Biological Chemistry. 2003; 278 (45):43885-43888. DOI: 10.1074/jbc.R300025200 - 56.
Sellick CA, Campbell RN, Reece RJ. Galactose metabolism in yeast-structure and regulation of the leloir pathway enzymes and the genes encoding them. International Review of Cell and Molecular Biology. 2008; 269 :111-150. DOI: 10.1016/S1937-6448(08)01003-4 - 57.
Shatton JB, Gruenstein M, Shay H, Weinhouse S. Enzymes of galactose synthesis in mammary gland and mammary tumors of the rat. The Journal of Biological Chemistry. 1965; 240 :22-28 - 58.
Verma S, Bharti B, Inusha P. Association of fungal sepsis and galactosemia. Indian Journal of Pediatrics. 2010; 77 (6):695-696. DOI: 10.1007/s12098-010-0082-5 - 59.
Cha SH, Wolfgang M, Tokutake Y, Chohnan S, Lane MD. Differential effects of central fructose and glucose on hypothalamic malonyl-CoA and food intake. Proceedings of the National Academy of Sciences of the United States of America. 2008; 105 (44):16871-16875. DOI: 10.1073/pnas.0809255105 - 60.
Menssen R, Schweiggert J, Schreiner J, Kusevic D, Reuther J, Braun B, et al. Exploring the topology of the Gid complex, the E3 ubiquitin ligase involved in catabolite-induced degradation of gluconeogenic enzymes. The Journal of Biological Chemistry. 2012; 287 (30):25602-25614. DOI: 10.1074/jbc.M112.363762